Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer.
Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Thompson LU, et al. Clin Cancer Res. 2005 May 15;11(10):3828-35. doi: 10.1158/1078-0432.CCR-04-2326. Clin Cancer Res. 2005. PMID: 15897583 Clinical Trial.
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, Gelmon K, Whelan T, Strasser-Weippl K, Rubin S, Sturtz K, Wolff AC, Winer E, Hudis C, Stopeck A, Beck JT, Kaur JS, Whelan K, Tu D, Parulekar WR. Goss PE, et al. Among authors: strasser weippl k. N Engl J Med. 2016 Jul 21;375(3):209-19. doi: 10.1056/NEJMoa1604700. Epub 2016 Jun 5. N Engl J Med. 2016. PMID: 27264120 Free PMC article. Clinical Trial.
Aromatase inhibitors for chemoprevention.
Goss PE, Strasser-Weippl K. Goss PE, et al. Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):113-30. doi: 10.1016/s1521-690x(03)00070-8. Best Pract Res Clin Endocrinol Metab. 2004. PMID: 14687601 Review.
Prevention strategies with aromatase inhibitors.
Goss PE, Strasser-Weippl K. Goss PE, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):372S-9S. doi: 10.1158/1078-0432.ccr-031210. Clin Cancer Res. 2004. PMID: 14734494
Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.
Lemieux J, Brundage MD, Parulekar WR, Goss PE, Ingle JN, Pritchard KI, Celano P, Muss H, Gralow J, Strasser-Weippl K, Whelan K, Tu D, Whelan TJ. Lemieux J, et al. Among authors: strasser weippl k. J Clin Oncol. 2018 Feb 20;36(6):563-571. doi: 10.1200/JCO.2017.75.7500. Epub 2018 Jan 12. J Clin Oncol. 2018. PMID: 29328860 Free PMC article. Clinical Trial.
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE. Strasser-Weippl K, et al. Breast Cancer Res. 2015 Apr 16;17(1):56. doi: 10.1186/s13058-015-0568-1. Breast Cancer Res. 2015. PMID: 25888246 Free PMC article.
Breast cancer in China.
Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE. Fan L, et al. Lancet Oncol. 2014 Jun;15(7):e279-89. doi: 10.1016/S1470-2045(13)70567-9. Lancet Oncol. 2014. PMID: 24872111 Review.
Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.
Strasser-Weippl K, Higgins MJ, Chapman JW, Ingle JN, Sledge GW, Budd GT, Ellis MJ, Pritchard KI, Clemons MJ, Badovinac-Crnjevic T, Han L, Gelmon KA, Rabaglio M, Elliott C, Shepherd LE, Goss PE. Strasser-Weippl K, et al. J Natl Cancer Inst. 2018 Sep 1;110(9):1003-1008. doi: 10.1093/jnci/djy017. J Natl Cancer Inst. 2018. PMID: 29554282 Free PMC article. Clinical Trial.
Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
Strasser-Weippl K, Steurer M, Kees M, Augustin F, Tzankov A, Dirnhofer S, Fiegl M, Simonitsch-Klupp I, Gisslinger H, Zojer N, Ludwig H. Strasser-Weippl K, et al. Cancer. 2006 Dec 15;107(12):2801-6. doi: 10.1002/cncr.22318. Cancer. 2006. PMID: 17103442
Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma.
Strasser-Weippl K, Ludwig H. Strasser-Weippl K, et al. Eur J Haematol. 2008 Nov;81(5):374-9. doi: 10.1111/j.1600-0609.2008.01126.x. Epub 2008 Jul 11. Eur J Haematol. 2008. PMID: 18637124
39 results
Jump to page